Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients

Abstract In this study, we compare the predictive value of clinical scoring systems that are already in use in patients with Coronavirus disease 2019 (COVID-19), including the Brescia-COVID Respiratory Severity Scale (BCRSS), Quick SOFA (qSOFA), Sequential Organ Failure Assessment (SOFA), Multilobul...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ishak San, Emin Gemcioglu, Salih Baser, Nuray Yilmaz Cakmak, Abdulsamet Erden, Seval Izdes, Ramis Catalbas, Mehmet Davutoglu, Berkan Karabuga, Ihsan Ates
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f3de5fff31834f5f81f9849c11b73dde
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f3de5fff31834f5f81f9849c11b73dde
record_format dspace
spelling oai:doaj.org-article:f3de5fff31834f5f81f9849c11b73dde2021-11-14T12:18:56ZBrescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients10.1038/s41598-021-01181-x2045-2322https://doaj.org/article/f3de5fff31834f5f81f9849c11b73dde2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-01181-xhttps://doaj.org/toc/2045-2322Abstract In this study, we compare the predictive value of clinical scoring systems that are already in use in patients with Coronavirus disease 2019 (COVID-19), including the Brescia-COVID Respiratory Severity Scale (BCRSS), Quick SOFA (qSOFA), Sequential Organ Failure Assessment (SOFA), Multilobular infiltration, hypo-Lymphocytosis, Bacterial coinfection, Smoking history, hyper-Tension, and Age (MuLBSTA) and scoring system for reactive hemophagocytic syndrome (HScore), for determining the severity of the disease. Our aim in this study is to determine which scoring system is most useful in determining disease severity and to guide clinicians. We classified the patients into two groups according to the stage of the disease (severe and non-severe) and adopted interim guidance of the World Health Organization. Severe cases were divided into a group of surviving patients and a deceased group according to the prognosis. According to admission values, the BCRSS, qSOFA, SOFA, MuLBSTA, and HScore were evaluated at admission using the worst parameters available in the first 24 h. Of the 417 patients included in our study, 46 (11%) were in the severe group, while 371 (89%) were in the non-severe group. Of these 417 patients, 230 (55.2%) were men. The median (IQR) age of all patients was 44 (25) years. In multivariate logistic regression analyses, BRCSS in the highest tertile (HR 6.1, 95% CI 2.105–17.674, p = 0.001) was determined as an independent predictor of severe disease in cases of COVID-19. In multivariate analyses, qSOFA was also found to be an independent predictor of severe COVID-19 (HR 4.757, 95% CI 1.438–15.730, p = 0.011). The area under the curve (AUC) of the BRCSS, qSOFA, SOFA, MuLBSTA, and HScore was 0.977, 0.961, 0.958, 0.860, and 0.698, respectively. Calculation of the BRCSS and qSOFA at the time of hospital admission can predict critical clinical outcomes in patients with COVID-19, and their predictive value is superior to that of HScore, MuLBSTA, and SOFA. Our prediction is that early interventions for high-risk patients, with early identification of high-risk group using BRCSS and qSOFA, may improve clinical outcomes in COVID-19.Ishak SanEmin GemciogluSalih BaserNuray Yilmaz CakmakAbdulsamet ErdenSeval IzdesRamis CatalbasMehmet DavutogluBerkan KarabugaIhsan AtesNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ishak San
Emin Gemcioglu
Salih Baser
Nuray Yilmaz Cakmak
Abdulsamet Erden
Seval Izdes
Ramis Catalbas
Mehmet Davutoglu
Berkan Karabuga
Ihsan Ates
Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients
description Abstract In this study, we compare the predictive value of clinical scoring systems that are already in use in patients with Coronavirus disease 2019 (COVID-19), including the Brescia-COVID Respiratory Severity Scale (BCRSS), Quick SOFA (qSOFA), Sequential Organ Failure Assessment (SOFA), Multilobular infiltration, hypo-Lymphocytosis, Bacterial coinfection, Smoking history, hyper-Tension, and Age (MuLBSTA) and scoring system for reactive hemophagocytic syndrome (HScore), for determining the severity of the disease. Our aim in this study is to determine which scoring system is most useful in determining disease severity and to guide clinicians. We classified the patients into two groups according to the stage of the disease (severe and non-severe) and adopted interim guidance of the World Health Organization. Severe cases were divided into a group of surviving patients and a deceased group according to the prognosis. According to admission values, the BCRSS, qSOFA, SOFA, MuLBSTA, and HScore were evaluated at admission using the worst parameters available in the first 24 h. Of the 417 patients included in our study, 46 (11%) were in the severe group, while 371 (89%) were in the non-severe group. Of these 417 patients, 230 (55.2%) were men. The median (IQR) age of all patients was 44 (25) years. In multivariate logistic regression analyses, BRCSS in the highest tertile (HR 6.1, 95% CI 2.105–17.674, p = 0.001) was determined as an independent predictor of severe disease in cases of COVID-19. In multivariate analyses, qSOFA was also found to be an independent predictor of severe COVID-19 (HR 4.757, 95% CI 1.438–15.730, p = 0.011). The area under the curve (AUC) of the BRCSS, qSOFA, SOFA, MuLBSTA, and HScore was 0.977, 0.961, 0.958, 0.860, and 0.698, respectively. Calculation of the BRCSS and qSOFA at the time of hospital admission can predict critical clinical outcomes in patients with COVID-19, and their predictive value is superior to that of HScore, MuLBSTA, and SOFA. Our prediction is that early interventions for high-risk patients, with early identification of high-risk group using BRCSS and qSOFA, may improve clinical outcomes in COVID-19.
format article
author Ishak San
Emin Gemcioglu
Salih Baser
Nuray Yilmaz Cakmak
Abdulsamet Erden
Seval Izdes
Ramis Catalbas
Mehmet Davutoglu
Berkan Karabuga
Ihsan Ates
author_facet Ishak San
Emin Gemcioglu
Salih Baser
Nuray Yilmaz Cakmak
Abdulsamet Erden
Seval Izdes
Ramis Catalbas
Mehmet Davutoglu
Berkan Karabuga
Ihsan Ates
author_sort Ishak San
title Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients
title_short Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients
title_full Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients
title_fullStr Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients
title_full_unstemmed Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients
title_sort brescia-covid respiratory severity scale (brcss) and quick sofa (qsofa) score are most useful in showing severity in covid-19 patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/f3de5fff31834f5f81f9849c11b73dde
work_keys_str_mv AT ishaksan bresciacovidrespiratoryseverityscalebrcssandquicksofaqsofascorearemostusefulinshowingseverityincovid19patients
AT emingemcioglu bresciacovidrespiratoryseverityscalebrcssandquicksofaqsofascorearemostusefulinshowingseverityincovid19patients
AT salihbaser bresciacovidrespiratoryseverityscalebrcssandquicksofaqsofascorearemostusefulinshowingseverityincovid19patients
AT nurayyilmazcakmak bresciacovidrespiratoryseverityscalebrcssandquicksofaqsofascorearemostusefulinshowingseverityincovid19patients
AT abdulsameterden bresciacovidrespiratoryseverityscalebrcssandquicksofaqsofascorearemostusefulinshowingseverityincovid19patients
AT sevalizdes bresciacovidrespiratoryseverityscalebrcssandquicksofaqsofascorearemostusefulinshowingseverityincovid19patients
AT ramiscatalbas bresciacovidrespiratoryseverityscalebrcssandquicksofaqsofascorearemostusefulinshowingseverityincovid19patients
AT mehmetdavutoglu bresciacovidrespiratoryseverityscalebrcssandquicksofaqsofascorearemostusefulinshowingseverityincovid19patients
AT berkankarabuga bresciacovidrespiratoryseverityscalebrcssandquicksofaqsofascorearemostusefulinshowingseverityincovid19patients
AT ihsanates bresciacovidrespiratoryseverityscalebrcssandquicksofaqsofascorearemostusefulinshowingseverityincovid19patients
_version_ 1718429324725452800